SCHEMBL22562972

SCHEMBL22562972

Nc1n[nH]c2cc(Nc3ccccc3C(F)(F)F)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 5/20 0.47
MAPK14 Q16539 5/20 0.47
MAPK8 P45983 4/20 0.47
JAK2 O60674 2/20 0.44
KDR P35968 3/20 0.44
EGFR P00533 2/20 0.44
AURKA O14965 2/20 0.44
AURKB Q96GD4 2/20 0.44
PLK4 O00444 1/20 0.44
ROCK2 O75116 1/20 0.44
CHEK2 O96017 1/20 0.44
NTRK1 P04629 1/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
CSF1R P07333 1/20 0.44
LYN P07948 1/20 0.44
KIT P10721 1/20 0.44
FLT1 P17948 1/20 0.44
EPHA2 P29317 1/20 0.44
FLT4 P35916 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24244917 0.82 SGK1 (0.52) MAPK10MAPK14MAPK8JAK2KDR
SCHEMBL6925012 0.80 MAPK10 (0.71) MAPK10MAPK14MAPK8JAK2FLT3
SCHEMBL30338305 0.77 MAPK10 (0.69) MAPK10MAPK14MAPK8JAK2KDR
SCHEMBL12907209 0.74 SCN5A (0.59) MAPK14JAK2KDREGFRAURKA
SCHEMBL1921413 0.73 ALDH1A1 (0.57) MAPK14AURKAKDM4EGAA
SCHEMBL27374191 0.72 MAPK10 (0.60) MAPK10MAPK14MAPK8JAK2KDR
SCHEMBL24244934 0.71 MAPK8 (0.50) MAPK10MAPK14MAPK8JAK2SGK1
SCHEMBL24244973 0.71 KDR (0.43) MAPK10MAPK14MAPK8JAK2KDR
SCHEMBL24244979 0.71 TRPA1 (0.55) MAPK10MAPK14MAPK8JAK2KDR
SCHEMBL2662677 0.69 TRPA1 (0.56) JAK2KDREGFRAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220041559-A1 BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS ROTTAPHARM BIOTECH S.R.L. (IT) 2022-02-10 US disclosed
EP-3725777-A1 BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS Rottapharm Biotech S.r.l. (IT) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220041559-A1 BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS PDXK, MAP4K2, PLK2 MAPK10 201/4885MAPK14 90/4885MAPK8 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.